Piramal Enterprises launch portable diagnostic device

The device that tests for 20 clinical parameters has been received well with 387 instruments being sold within just 45 days of the test marketing launch


Piramal Enterprises' diagnostic division recently announced the launch of "QDx Instacheck" -Right-here-Right-now. It is touted to be a first-of-its-kind portable diagnostic device that is specifically designed to perform 20 clinical parameters and deliver quantitative results within 3 - 15 minutes. It covers wide therapeutic areas including cardiovascular disease, hormonal imbalance, emergency care, diabetes, oncology, infections, pregnancy and infertility management.

This portable and affordable device is considered to deliver quantitative test results with high accuracy. The device is virtually maintenance free and can be operated very easily with minimal training requirements. QDx Instacheck is particularly useful for doctors' clinics, emergency care units (such as ICU, CCU), hospitals, pathological labs, IVF centres, ambulance services, pharmaceutical companies and NGOs engaged in healthcare services.

Commenting on the launch Mr. Vijay Shah, Executive Director and Chief Operating Officer, Piramal Enterprises said, "It is our endeavour to empower the medical community such as gynaecologists, cardiologists, diabetologists, general physicians, pathological labs to perform critical tests Right-here-Right-now with minimum investment and lowest operating expenses and finally making treatment decisions faster. The launch of QDx Instacheck is in line with our division's vision of bringing affordable instant diagnostic solution through our point-of-care product range. This 1.3 kg portable device is the first-of-its-kind revolutionary instant diagnostic device in the Indian market that is poised to change traditional diagnostic methods to instant diagnosis."

QDx Instacheck has been commercially test marketed from January to March 2013 across various parts of India through our field force and over 250 authorised distributors. The formal launch of the product is scheduled in April 2013. A record of 387 instruments was sold in just 45 days from test marketing launch.

2 Comment Comment 1 - 1 of 1

Jose 10 April 2013 at 06:52 AM

Oui, K ,dans l temps,j ai connu un photographe qui mais, ici, esyases donc les douches e9cossaises: c est souverain! Et puis au lieu de stresser, arreates donc ton char, prends ton jet(ame8nes-nous ton innnnnimitable TART AL POM -ave9 lassen-) avant de repartir en navette spaciale pour nous envoyer encore d autres infos side9rales.-Babs-:pour les ceux qui savent.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology


Taro Announces Appointment of Interim CEO

Friday, 2 Dec 2016   |   Taro Pharmaceutical Industries Ltd.

Business Wire India Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”)

Florida's Parrish Medical Center is the First Hospital to Commit to All

Friday, 2 Dec 2016   |   Patient Safety Movement Foundation

Business Wire India The Patient Safety Movement Foundation (PSMF) is very proud to announce that Parrish

GVK BIO Announces Launch of a GMP Compliant Analytical Services Laboratory

Friday, 2 Dec 2016   |   GVK BIO

Business Wire IndiaGVK Biosciences, one of Asia’s leading life sciences service organizations today

BusinessWire India.com - Pharmaceutical


Taro Announces Appointment of Interim CEO

Friday, 2 Dec 2016   |   Taro Pharmaceutical Industries Ltd.

Business Wire India Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”)

The Bitter Truth About Sugar!

Wednesday, 30 Nov 2016   |   Manipal Hospitals

Business Wire IndiaOn average, an individual having three square meals a day consumes up to 148 grams

BusinessWire India.com - Medical Devices


BGS Global Hospital Performs Successful Use of Spy Glass to Treat Large

Thursday, 1 Dec 2016   |   BGS Global Hospitals

Business Wire India Spy Glass destroys stones that form in or become lodged in the Common Bile Duct

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email